Clinical trial · Interventional
Feasibility of High Intensity Interval Training in Survivors of Childhood, Adolescent, and Young Adult Hodgkin Lymphoma
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This pilot study evaluates the feasibility of a 12-week high intensity interval training (HIIT) program in survivors of childhood, adolescent, and young adult Hodgkin lymphoma within 24 months of completing treatment. Preliminary efficacy of the HIIT intervention for improved cardiorespiratory fitness, body composition, physical function, autonomic response to exercise, peripheral neuropathy, biological aging markers, and physical activity will also be evaluated. Primary Objective: To determine the feasibility of a 12-week high intensity interval training (HIIT) program in survivors of childhood, adolescent, and young adult Hodgkin lymphoma within 24 months of completing treatment. Feasibility will be assessed by: * Participation Rate: Number of eligible survivors approached who enroll. * Completion Rate: Number of scheduled HIIT sessions attended and number of enrolled participants who complete post-intervention testing.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hodgkin Lymphoma | Hodgkin Lymphoma | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| High Intensity Interval Training (HIIT) | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- HIIT Intervention Group
- description
- Participants will complete a 12-week HIIT program with three 25-minute sessions per week. Each session includes warm-up, five cycles of high-intensity intervals (80-95% peak HR) and recovery periods (50-60% peak HR), and cool-down.
- interventionNames
- Behavioral: High Intensity Interval Training (HIIT)
Primary outcomes (2)
- measure
- Participation rate (percent of eligible participants approached who enroll)
- timeFrame
- Trial completion (12 weeks)
- description
- Descriptive statistics will be reported
- measure
- Completion rate (percentage of scheduled HIIT sessions attended and percentage of post-intervention testing sessions completed)
- timeFrame
- Trial completion (12 weeks)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 10 Years
- Maximum age
- 25 Years
Show eligibility criteria text
Inclusion Criteria: * Participant has been diagnosed with Hodgkin lymphoma between the ages of 10 to 25 years. * Participant is between the ages of \>10 and \<25 years old the time of enrollment. * Participant has completed treatment (end of chemotherapy for those not receiving radiation therapy or end of radiation therapy) for Hodgkin lymphoma within 24 months prior to enrollment and recovered from any acute treatment-related adverse events. * Participant has been medically cleared to participate in physical activity. * Participant verbalizes understanding of directions for use of the web-based platform on the study provided iPad and heart rate monitor. Exclusion Criteria: * Participant has evidence of relapsed disease. * Participant has a diagnosis of acute heart failure. * Participant reports currently participating in HIIT training or \>420 minutes per week of moderate to vigorous physical activity. * Female participant who is currently pregnant.
References
Publications (0)
Data not yet available